Ponalfil trial for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: Long-term results

This project was supported in part by the ISCIII (PI14/01971 and PI19/01828), co-funded by ERDF/ESF, “A way to make Europe”/“Investing in your future,” CERCA/Generalitat de Catalunya SGR 2017 288 (GRC)/“La Caixa.” This project has also been supported by Incyte Biosciences International S.a.r.l. with...

Descripción completa

Detalles Bibliográficos
Autores: Ribera, Josep-Maria, Morgades, Mireia, Ribera, Jordi, Montesinos, Pau, Cano-Ferri, Isabel, López Martínez, Pilar, Esteve, Jordi, Esteban, Daniel, García-Fortes, María, Alonso, Natalia, González-Campos, José, Bermúdez, Arancha, Torrent, Anna, Genescà, Eulàlia, Maluquer, Clara, Martínez-López, Joaquín, García-Sanz, Ramón
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/403592
Acceso en línea:http://hdl.handle.net/10261/403592
https://api.elsevier.com/content/abstract/scopus_id/85189206182
Access Level:acceso abierto
Descripción
Sumario:This project was supported in part by the ISCIII (PI14/01971 and PI19/01828), co-funded by ERDF/ESF, “A way to make Europe”/“Investing in your future,” CERCA/Generalitat de Catalunya SGR 2017 288 (GRC)/“La Caixa.” This project has also been supported by Incyte Biosciences International S.a.r.l. with study medication and financial support. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116026. This Joint Undertaking receives support from the “European Union's Horizon 2020 research and innovation and EFPIA.”

Similares en LA Referencia